Where does Sanofi Pasteur Biologics, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sanofi Pasteur Biologics, LLC ranks #16,329 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sanofi Pasteur Biologics, LLC hold?

Sanofi Pasteur Biologics, LLC holds 18 US utility patents granted between 2015 and 2022, spanning 9 technology areas.

What is Sanofi Pasteur Biologics, LLC's Innovation Score?

Sanofi Pasteur Biologics, LLC has an Innovation Score of 37.2 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Sanofi Pasteur Biologics, LLC focus on?

Sanofi Pasteur Biologics, LLC's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 15 patents, ranking #1,511 of 7,163 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Sanofi Pasteur Biologics, LLC's patent grant rate increasing or decreasing?

Sanofi Pasteur Biologics, LLC's recent grant velocity is -71% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Sanofi Pasteur Biologics, LLC's patents?

Sanofi Pasteur Biologics, LLC's patents average 20.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sanofi Pasteur Biologics, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Sanofi Pasteur Biologics, LLC

USPTO PatentsView assignee record - 18 granted patents across 9 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sanofi ranks #16,329 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 9 technology areas.

#16,329
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.2/100): 20.7
avg claims per patent: -71%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16329 · US Corporation #16,329 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #16,329/49,997
PHOTO-FINISH Sakura Color Products
CPC-NARROW A61K · 9 areas
INNOV-THIN 37.2/100
CLAIMS-DENSE 20.7 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -71% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sakura Color Products Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sanofi’s 37.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (27%) Velocity 4.0 pts (11%) Breadth 10.6 pts (28%) Claim depth 12.4 pts (33%)

Qualcomm Incorporated · highest

85
Sanofi Pasteur… · this assignee

37
3D Lighting… · lowest

7

What this shows Sanofi's Innovation Score is 37.2/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Sanofi?

Each dot is one of Sanofi’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sanofi’s own 20.7 claims/patent is ABOVE the 11.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Sanofi vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sanofi's grants concentrate

Sanofi Pasteur Biologics, LLC is a focused PatentsView assignee: 9 CPC subclasses with 83.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2017. By volume, Sanofi sits between Sakura Color Products Corporation and SCT Technology, Ltd..

Sanofi's three-year grant acceleration

Sanofi Pasteur Biologics, LLC shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sakura Color Prod…

18
Salvagnini Italia…

18
Samsung Electro-m…

18
SAN Ford Machinery

18
Sanwa Denki Kogyo

18
Schunk Kohlenstof…

18
Science House

18
SCT Technology

18
Sanofi Pasteur Bi… ◀

18

What this shows Sanofi holds 18 patents at rank #16,325, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sanofi

By rank, the assignees closest to #16,325 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Sanofi's primary technology class.

Sanofi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sanofi Pasteur Biologics, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	16.7%
2016	5	27.8%
2017	1	5.6%
2018	1	5.6%
2019	4	22.2%
2020	1	5.6%
2022	3	16.7%

Which technologies does Sanofi Pasteur Biologics, LLC patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 15

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 12

C07K - Peptides 7

Y02A - Technologies FOR Adaptation TO Climate Change 4

B01D - Separation 3

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Sanofi Pasteur Biologics, LLC's patent record in context - here's where to go next.

Sanofi Pasteur Biologics, LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 83.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #16,329 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sanofi Pasteur Biologics, LLC against Sakura Color Products Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.